Home › Lymphoma › Texas › Dallas

Pag-aaral pangklinika para sa Lymphoma sa Dallas, TX

Isang pag-aaral para sa Lymphoma ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Dallas. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)

Nagre-recruitPhase 1/2

Call for Information (Investigational Site 0054), Dallas

6 Months – 17 Years · Lahat ng kasarian · Na-update Nob 13, 2026 · NCT02332668

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Nagre-recruitPhase 1/2

Baylor Scott & White Research Institute, Texas Oncology, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT06343311

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Nagre-recruitPhase 1/2

The University of Texas Southwestern Medical Center - Harold C Simmons Comprehensive Cancer Center, Dallas

Hanggang edad 25 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT04094610

CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

Nagre-recruitPhase 1/2

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

12 Months – 21 Years · Lahat ng kasarian · Na-update Set 11, 2026 · NCT04870944

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Nagre-recruitPhase 1/2

Baylor Scott & White Health, Dallas

Edad 12 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT04588922

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Nagre-recruitPhase 1/2

Baylor University Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT05826535

DALY II USA/ MB-CART2019.1 for DLBCL

Nagre-recruitPhase 2

UT Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 13, 2026 · NCT04792489

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

Nagre-recruitObservasyonal na pag-aaral

UT Southwestern/Simmons Cancer Center-Dallas, Dallas

Lahat ng edad · Lahat ng kasarian · Na-update May 18, 2026 · NCT01790152

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

Nagre-recruitPhase 1/2

University of Texas(UT) Southwestern-Children's Medical Center, Dallas

Edad 12 hanggang 95 · Lahat ng kasarian · Na-update Abr 15, 2026 · NCT04329728

A Safety and Efficacy Study of HCB101, Fc-fusion Protein Targeting SIRPα-CD47 Pathway, in Solid or Hematological Tumors

Nagre-recruitPhase 1

UT Southwestern Medical Center, Dallas

Edad 18 pataas · Lahat ng kasarian · Na-update Peb 4, 2026 · NCT05892718

Pag-aaral para sa Lymphoma sa ibang lungsod

Iba pang pag-aaral sa Dallas

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.